Nitin Joshi

Editor-in-Chief of 𝘿𝙧𝙪𝙜 𝙎𝙖𝙛𝙚𝙩𝙮, the official journal of the International Society of Pharmacovigilance (@ISoPonline). All views are my own.

[Nitin Joshi @DrugSafetyJ]

Our paper on Paper Mills now published in @PLOSBiology
#OpenAccess #ResearchIntegrity #PaperMills

[Nitin Joshi @DrugSafetyJ]

👉𝙋𝙚𝙣𝙘𝙞𝙡 𝙞𝙣 𝙩𝙝𝙚 𝙙𝙖𝙩𝙚 - 𝗧𝗵𝘂𝗿𝘀𝗱𝗮𝘆 7 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 2024 𝗮𝘁 09:00 𝗨𝗧𝗖
@ISoPonline members - Listen to the authors of the 𝗥𝗘𝗔𝗗𝗨𝗦-𝗣𝗩 𝗚𝘂𝗶𝗱𝗲𝗹𝗶𝗻𝗲𝘀
https://t.co/5mu90EuGDb
👉The presentation will be followed by a Q&A session

[Nitin Joshi @DrugSafetyJ]

@montastrucf I am glad you liked it @montastrucf

[Nitin Joshi @DrugSafetyJ]

I am truly honoured and grateful to be admitted as a Fellow of the International Society of Pharmacovigilance (FISoP), recognising my contributions to the discipline of pharmacovigilance and my service to @ISoPonline
#ISoP2024Montreal #ISoPFellow #Pharmacovigilance #DrugSafety

[Nitin Joshi @DrugSafetyJ]

📢 Excited to announce the newest addition to our 𝘿𝙧𝙪𝙜 𝙎𝙖𝙛𝙚𝙩𝙮 family - a heartfelt welcome to Professor Nicole Pratt (@nicolepratt_ @UniversitySA), who has joined the Editorial Board of 𝘿𝙧𝙪𝙜 𝙎𝙖𝙛𝙚𝙩𝙮.
🚀 #NewBeginnings #DrugSafetyCommunity #Pharmacovigilance

[Nitin Joshi @DrugSafetyJ]

👉🏻 𝗦𝗲𝗲 𝘆𝗼𝘂 𝗻𝗲𝘅𝘁 𝘄𝗲𝗲𝗸 𝗶𝗻 𝗠𝗼𝗻𝘁𝗿𝗲𝗮𝗹
https://t.co/jzd8mGUV8Y

#ISoP2024Montreal #Pharmacovigilance

[Nitin Joshi @DrugSafetyJ]

📢 Thrilled to announce the newest addition to our 𝘿𝙧𝙪𝙜 𝙎𝙖𝙛𝙚𝙩𝙮 family - a heartfelt welcome to Dr Florence van Hunsel (@Lareb_NL), who has joined the Editorial Board of 𝘿𝙧𝙪𝙜 𝙎𝙖𝙛𝙚𝙩𝙮
https://t.co/KkrKGZl7s2
#NewBeginnings #DrugSafetyCommunity #Pharmacovigilance

[Nitin Joshi @DrugSafetyJ]

𝘗𝘢𝘳𝘢𝘤𝘦𝘵𝘢𝘮𝘰𝘭 𝘥𝘰𝘴𝘪𝘯𝘨 𝘦𝘳𝘳𝘰𝘳𝘴 𝘤𝘰𝘯𝘵𝘪𝘯𝘶𝘦 𝘵𝘰 𝘰𝘤𝘤𝘶𝘳, 𝘸𝘪𝘵𝘩 𝘳𝘦𝘭𝘢𝘵𝘪𝘷𝘦𝘭𝘺 𝘩𝘪𝘨𝘩 𝘳𝘢𝘵𝘦𝘴 𝘰𝘧 𝘩𝘰𝘴𝘱𝘪𝘵𝘢𝘭𝘪𝘴𝘢𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘭𝘪𝘷𝘦𝘳 𝘪𝘯𝘫𝘶𝘳𝘺
https://t.co/lzK84s1a2g
#OpenAccess #Pharmacovigilance #Paracetamol

[Nitin Joshi @DrugSafetyJ]

📢Looking forward to attending the 23 Annual Meeting of the @ISoPonline in Montreal. I will be conducting a Meet-the-Editor session on 04 Oct. Bring along all your publishing queries. Let’s have an engaging discussion. See you there!✨
https://t.co/vz4AfBOJx8
#ISoP2024Montreal

[Nitin Joshi @DrugSafetyJ]

𝗖𝗢𝗩𝗜𝗗-19 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱 𝗔𝗰𝘂𝘁𝗲 𝗔𝗽𝗽𝗲𝗻𝗱𝗶𝗰𝗶𝘁𝗶𝘀
Data from Italy showed 𝗡𝗼 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗶𝗼𝗻 between COVID-19 vaccines (BNT162b, ChAdOx1-S, mRNA-1273 and Ad26.COV2-S) and acute appendicitis.
https://t.co/7hjLKYBVpA
#OpenAccess #Covid19Vaccines

[Nitin Joshi @DrugSafetyJ]

Now published: our second review article in the Q&A format
https://t.co/lHP5AaEjCJ
#OpenAccess #Pharmacovigilance

[Nitin Joshi @DrugSafetyJ]

👉 From 𝗗𝗿𝘂𝗴 𝗦𝗮𝗳𝗲𝘁𝘆 archives
𝗧𝗵𝗲 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗗𝗶𝗰𝘁𝗶𝗼𝗻𝗮𝗿𝘆 𝗳𝗼𝗿 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗔𝗰𝘁𝗶𝘃𝗶𝘁𝗶𝗲𝘀 (𝗠𝗲𝗱𝗗𝗥𝗔)
Full Link https://t.co/5nZTyEEBgt

[Nitin Joshi @DrugSafetyJ]

Not Just Another Reporting Guideline? Here’s Why READUS-PV is a Major Step Forward
Read this commentary for free by our Editorial Board member Professor Yoon Loke University of East Anglia)
https://t.co/bKxydqBRIZ
#Pharmacovigilance

[Nitin Joshi @DrugSafetyJ]

👉 Just published
The READUS-PV guidelines on the Reporting of a Disproportionality Analysis for Drug Safety Signal Detection
https://t.co/5mu90EuGDb
https://t.co/G657WfkpMO
#OpenAcess #Pharmacovigilance

[International Society of Pharmacovigilance (ISoP) @ISoPonline]

Another successful PV Journal club in the books! 📚 With 43 engaged participants, huge thanks to Nitin Joshi and Rebecca Chandler for for chairing it with excellence! 👏 #Pharmacovigilance #JournalClub

[Nitin Joshi @DrugSafetyJ]

𝗣𝗲𝗲𝗿 𝗥𝗲𝘃𝗶𝗲𝘄 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝘃𝗶𝗴𝗶𝗹𝗮𝗻𝗰𝗲: 𝗟𝗲𝗻𝘀 𝗼𝗻 𝗗𝗶𝘀𝗽𝗿𝗼𝗽𝗼𝗿𝘁𝗶𝗼𝗻𝗮𝗹𝗶𝘁𝘆 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀
It was an excellent experience to work together on this subject alongside some of the leading experts in the field
https://t.co/eeYpzUiSGo

[Nitin Joshi @DrugSafetyJ]

👉The Critical Role of Regulations in Pharmacovigilance
👉Guest edited by Kenneth Hartigan-Go and Raymond Chua, this collection highlights the indispensable intersect between health regulations and the discipline of pharmacovigilance.
https://t.co/OBwWENkL43

[Nitin Joshi @DrugSafetyJ]

📢 𝙄𝙎𝙤𝙋 𝙢𝙚𝙢𝙗𝙚𝙧𝙨 - 𝙧𝙚𝙜𝙞𝙨𝙩𝙚𝙧 𝙛𝙤𝙧 𝙩𝙝𝙚 𝙣𝙚𝙭𝙩 𝙟𝙤𝙪𝙧𝙣𝙖𝙡 𝙘𝙡𝙪𝙗 𝙝𝙚𝙧𝙚 ⬇️⬇️
https://t.co/dRVNBpOgIA
Presented by Nele Brusselaers
Based on their recent Drug Safety article https://t.co/7ODlPoKPRJ
@ISoPonline #Pharmacovigilance #JournalClub

[Nitin Joshi @DrugSafetyJ]

Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ DILI Initiative
Read the full article at https://t.co/bUydhEM8Ih
#OpenAccess #LiverInjury #DILI

[Nitin Joshi @DrugSafetyJ]

🌟Exciting News! Dr Priya Bahri (EMA) and Pr. Anthony Cox (@Cox_A_R, University of Birmingham) are now part of the Editorial Board of Drug Safety. We extend a warm welcome to both as they become valuable members of the Drug Safety family
https://t.co/KkrKGZl7s2
#NewBeginnings